Cerebral, Splanchnic, and Renal Transit Time Measurement and Blood Volume Estimation Using Contrast-Enhanced Ultrasonography.


Journal

Ultrasound quarterly
ISSN: 1536-0253
Titre abrégé: Ultrasound Q
Pays: United States
ID NLM: 8809459

Informations de publication

Date de publication:
01 Dec 2024
Historique:
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

We aimed to measure cerebral, splanchnic, and renal transit times and the associated blood volumes using contrast ultrasound. In healthy individuals, regional transit times were calculated from time-intensity curves generated as ultrasound contrast passed through the associated inflow and outflow vessels. These included the internal carotid artery and internal jugular vein (brain), the superior mesenteric artery and portal vein (intestines), and the renal artery and renal vein (kidney). An organ's blood volume relative to the stroke volume delivered to that organ with each cardiac cycle was calculated from the product of heart rate and transit time of contrast passage through the associated vascular bed. The fraction of systemic stroke volume received by each organ was calculated from the respective velocity-time integral and inflow vessel cross-sectional area and used to estimate absolute organ blood volume. The cohort consisted of 16 participants (age: 42 ± 13 years; 5 female) without known cerebrovascular, gastrointestinal, or renal disease. Cerebral, splanchnic, and renal transit times were obtained for 15, 14, and 8 individuals, respectively. Anatomic variability of the renal vessels confounded the acquisition of renal transit times. For all organs, transit times were reproducible and the associated blood volumes were generally comparable to reference values. Cerebral, gastrointestinal, and renal transit times/blood volumes can be reasonably acquired from contrast ultrasound, although the latter is less reliably available. Assessment of the impact on regional blood volumes of pharmacologic or other interventions is a next step toward clinical application of this technique.

Identifiants

pubmed: 39282951
doi: 10.1097/RUQ.0000000000000687
pii: 00013644-202412000-00002
pii:
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Seraphim A, Knott KD, Menacho K, et al. Prognostic value of pulmonary transit time and pulmonary blood volume estimation using myocardial perfusion CMR. J Am Coll Cardiol Img. 2021;14:2107–2119.
Houard L, Amzulescu MS, Colin G, et al. Prognostic value of pulmonary transit time by cardiac magnetic resonance on mortality and heart failure hospitalization in patients with advanced heart failure and reduced ejection fraction. Circ Cardiovasc Imaging. 2021;14:e011680.
Monahan K, Coffin S, Lawson M, et al. Pulmonary transit time from contrast echocardiography and cardiac magnetic resonance imaging: comparison between modalities and the impact of region of interest characteristics. Echocardiography. 2019;36:119–124.
Brittain EL, Doss LN, Saliba L, et al. Feasibility and diagnostic potential of pulmonary transit time measurement by contrast echocardiography: a pilot study. Echocardiography. 2015;32:1564–1571.
Albrecht T, Blomley MJK, Cosgrove DO, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 1999;353:1579–1583.
Monahan K, Lenihan D, Brittain EL, et al. The relationship between pulmonary artery wedge pressure and pulmonary blood volume derived from contrast echocardiography: a proof of concept study. Echocardiography. 2018;35:1266–1270.
Monahan K, Brittain E, Tolle JJ. Measurement of pulmonary transit time and estimation of pulmonary blood volume after exercise using contrast echocardiography. J Echocardiogr. 2022;21:16–22.
Boronyak SM, Monahan K, Brittain EL, et al. An inflection point method for the determination of pulmonary transit time from contrast echocardiography. IEEE Trans Biomed Eng. 2015;62:1853–1861.
Lewis JF, Kuo LC, Nelson JG, et al. Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. Circulation. 1984;70:425–431.
Leggett RW, Williams LR. Suggested reference values for regional blood volumes in humans. Health Phys. 1991;60:139–154.
Williams LR, Leggett RW. Reference values for resting blood flow to organs of man. Clin Phys Physiol Meas. 1989;10:187–217.
Xing C-Y, Tarumi T, Liu J, et al. Distribution of cardiac output to the brain across the adult lifespan. J Cereb Blood Flow Metab. 2017;37:2848–2856.
Puls I, Becker G, Maurer M, et al. Cerebral arteriovenous transit time (CTT): a sonographic assessment of cerebral microcirculation using ultrasound contrast agents. Ultrasound Med Biol. 1999;25:503–507.
Vinke EJ, Kortenbout AJ, Eyding J, et al. Potential of contrast-enhanced ultrasound as a bedside monitoring technique in cerebral perfusion: a systematic review. Ultrasound Med Biol. 2017;43:2751–2757.
Copen WA, Lev MH, Rapalino O. Brain perfusion: computed tomography and magnetic resonance techniques. In: Masdeu JC, Gonzalez RG, eds. Handbook of Clinical Neurology, Neuroimaging Part I. Cambridge MA: Elsevier; 2016:117–135.
Fudim M, Parikh K, Ganesh A, et al. Splanchnic nerve block with botulinum toxin for therapy of chronic heart failure – mechanism of action (SPONGE-HF). Eur J Heart Fail. 2023;25:594–596.
Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139:e840–e878.
Ajibowo AO, Okobi OE, Emore E, et al. Cardiorenal syndrome: a literature review. Cureus. 2023;15:e41252.
Racosta JM, Kimpinski K. Autonomic function and brain volume. Clin Auton Res. 2016;26:377–383.
Smith EC, Diedrich A, Raj SR, et al. Splanchnic venous compression enhances the effects of ß-blockade in the treatment of postural tachycardia syndrome. J Am Heart Assoc. 2020;9:e016196.
Olshansky B, Cannom D, Fedorowski A, et al. Postural orthostatic tachycardia syndrome (POTS): a critical assessment. Prog Cardiovasc Dis. 2020;63:263–270.
Biaggioni I. Blood pressure regulation in autonomic failure by dietary sodium, blood volume and posture. Auton Neurosci. 2021;236:102891.

Auteurs

Ken Monahan (K)

Division of Cardiovascular Medicine.

Deborah Kerrigan (D)

Department of Neurology.

Cyndya Shibao (C)

Division of Clinical Pharmacology.

William Fissell (W)

Division of Nephrology.

Roman Perri (R)

Division of Gastroenterology.

Virginia Planz (V)

Department of Radiology, Vanderbilt University Medical Center, Nashville, TN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH